Luteinizing Hormone (LH)

Catalogue Number: 996-30
Availability Discontinued - See 996-31
Product Name Luteinizing Hormone
Source Human Pituitary Glands
Catalogue Number 996-30
Purity > 50% (SDS-PAGE)
Form Lyophilized
Activity > 5,000 IU/mg
Contaminants FSH: < 75 IU/mg (All assayed < 2.0% w/w)
TSH: < 0.17 IU/mg
PRL: < 0.02 mg/mg
hGH: < 0.02 mg/mg
Formulation Lyophilized from 50 mM ammonium bicarbonate.
Reconstitution Reconstitute using neutral pH buffer of choice. Avoid extreme high and low pH
Related Products 996-11 - FSH antigen from human pituitary gland
996-31 - LH antigen from human pituitary gland
996-21 - hGH antigen from human pituitary gland
Storage 2-8°C
Recertification 5 years
Infectious Disease Testing Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV, HBsAg, and syphilis by FDA approved methods.
Molecular Weight ~26,000
CAS Number 39341-83-8
Synonyms LH, Lutropin

Lee Biosolutions is the leading supplier of Human Luteinizing Hormone (LH) for research and clinical diagnostic manufacturing.

Technical support, bulk quantities and aliquoting available, email for more details.

Luetinzing Hormone (LH), also known as lutropin, is a heterodimeric glycoprotein. Each monomeric unit is a glycoprotein molecule; one alpha and one beta subunit make the full, functional protein. Luteinizing Hormone is essential for reproduction in both males and females.

According to Labtest online: LH is often used in conjunction with other tests (FSH, testosterone, estradiol and progesterone) in the workup of infertility in both men and women. Luteinizing Hormone levels are also useful in the investigation of menstrual irregularities and to aid in the diagnosis of pituitary disorders or diseases involving the ovaries or testes.

Luteinzing Hormone is sometimes measured in relation to gonadotropin releasing hormone (GnRH) to distinguish between primary or secondary disorders involving the hypothalamus, pituitary gland, or the gonads. GnRH is the hormone produced by the hypothalamus that stimulates the pituitary to release LH and FSH. For this test, a baseline blood sample is drawn and then the patient is given an injection of GnRH. Subsequent blood samples are drawn at specified times and the level of LH is measured. This test can help differentiate between disease of the ovaries or testes (primary) and a disorder of the pituitary or hypothalamus (secondary).

Add to Cart